Donoghue Forlines’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $2.26M | Buy |
|
|||||
2024
Q1 | – | Sell |
|
|||||
2023
Q4 | $1.31M | Sell |
|
|||||
2023
Q3 | $1.29M | Sell |
|
|||||
2023
Q2 | $1.32M | Sell |
|
|||||
2023
Q1 | $1.83M | Buy |
|
|||||
2022
Q4 | $1.91M | Buy |
|
|||||
2022
Q3 | $1.43M | Sell |
|
|||||
2022
Q2 | $2.94M | Sell |
|
|||||
2022
Q1 | $3.42M | Buy |
|
|||||
2021
Q4 | $3.2M | Sell |
|
|||||
2021
Q3 | $2.69M | Buy |
|
|||||
2021
Q2 | – | Sell |
|
|||||
2021
Q1 | $1.59M | Buy |
|
|||||
2020
Q4 | $1.17M | Buy |
|
|||||
2018
Q4 | – | Sell |
|
|||||
2018
Q3 | $16.4M | Sell |
|
|||||
2018
Q2 | $18.1M | Sell |
|
|||||
2018
Q1 | $17.4M | Buy |
|
|||||
2017
Q4 | – | Sell |
|
|||||
2017
Q3 | $16.7M | Sell |
|
|||||
2017
Q2 | $16.2M | Buy |
|